estudio soul semaglutide Effects of oral on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial 🩺 Semaglutida Oral: Un Avance

The concurrent activation of GLP-1, GIP, and glucagon receptors has been studied as a means of examining the synergistic interplay between satiety regulation and fat oxidation pathways

The more important factor is what you eat alongside it rather than the bread itself

& Fiotakis, C

According to the mechanisms shown in the graphic, Retatrutide acts on: GLP-1 receptors GIP receptors Glucagon receptors By targeting all three pathways, Retatrutide supports multiple systems in the body at the same time, rather than relying on appetite suppression alone

Heres the scoop on how the FDA-approved treatments play into this

But when I turned 45 and perimenopause came knocking on my door, I started steadily gaining weight each year